Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, Brookfield Corporation (BN) has a Wall Street consensus price target of $54.40, based on estimates from 9 covering analysts. With the stock currently trading at $45.84, this represents a potential upside of +18.7%. The company has a market capitalization of $102.89B.
Analyst price targets range from a low of $49.00 to a high of $61.00, representing a 22% spread in expectations. The median target of $52.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BN trades at a trailing P/E of 9999.0x and forward P/E of 16.4x. Analysts expect EPS to grow +404.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $45.84, with bear and bull scenarios of $24.55 and $139.76 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonQuick answers to the most common questions about buying BN stock.
Brookfield Corporation (BN) has a consensus 12-month price target of $54.4, implying 18.7% upside from $45.84. The 9 analysts covering BN see moderate appreciation potential.
BN has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $54.4 implies 18.7% upside from current levels.
With a forward P/E of 16.4454x, BN trades at a relatively low valuation. The consensus target of $54.4 implies 18.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $61 for BN, while the most conservative target is $49. The consensus of $54.4 represents the median expectation. Our quantitative valuation model projects a bull case target of $140 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BN stock forecast based on 9 Wall Street analysts shows a consensus price target of $54.4, with estimates ranging from $49 (bear case) to $61 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $46, with bear/bull scenarios of $25/$140.
Our quantitative valuation model calculates BN's fair value at $46 (base case), with a bear case of $25 and bull case of $140. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
BN trades at a forward P/E ratio of 16.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 9999.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on BN, with a "Buy" consensus rating and $54.4 price target (18.7% upside). 8 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BN analyst price targets range from $49 to $61, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $54.4 consensus represents the middle ground. Our model's $25-$140 range provides an independent fundamental perspective.